Bicycle Therapeutics Plc (BCYC)
3.88
+0.05
(+1.31%)
USD |
NASDAQ |
Sep 11, 16:00
3.88
0.00 (0.00%)
After-Hours: 16:53
Bicycle Therapeutics Gross Profit (TTM) : 55.79M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 55.79M |
| March 31, 2026 | 57.46M |
| December 31, 2025 | 66.08M |
| September 30, 2025 | 21.52M |
| June 30, 2025 | 12.11M |
| March 31, 2025 | 18.60M |
| December 31, 2024 | 28.09M |
| September 30, 2024 | 29.81M |
| June 30, 2024 | 32.94M |
| March 31, 2024 | 34.99M |
| December 31, 2023 | 20.50M |
| September 30, 2023 | 18.61M |
| June 30, 2023 | 14.97M |
| March 31, 2023 | 5.182M |
| December 31, 2022 | 1.812M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Autolus Therapeutics Plc | 15.09M |
| Biodexa Pharmaceuticals Plc | -0.2472M |
| Akari Therapeutics Plc | 0.00 |
| DBV Technologies SA | -12.78M |
| Cellectis SA | 37.38M |